Prescription of Prophylactic Antiemetic Drugs for Patients Receiving Chemotherapy With Minimal and Low Emetic Risk-Reference-Cited by-同舟云学术

Prescription of Prophylactic Antiemetic Drugs for Patients Receiving Chemotherapy With Minimal and Low Emetic Risk

Published:2017-03-01 Issue:3 Volume:3 Page:344
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Okuyama Ayako¹,Nakamura Fumiaki²,Higashi Takahiro³

Affiliation:

1. Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan

2. Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan3Department of Public Health, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

3. Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success;Critical Reviews in Oncology/Hematology;2024-09

2. 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting;ESMO Open;2024-02

3. 2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential;Supportive Care in Cancer;2023-12-19

4. PRESCRIPTION PATTERN OF PROPHYLACTIC ANTIEMETICS IN BREAST CANCER PATIENTS: A RETROSPECTIVE OBSERVATIONAL STUDY IN A TERTIARY CARE HOSPITAL;Asian Journal of Pharmaceutical and Clinical Research;2023-06-07

5. Factors affecting the implementation of guideline-based prophylactic antiemetic therapy for chemotherapy-induced nausea and vomiting in Japan: a protocol for a hospital-based qualitative study;BMJ Open;2022-06